menu
    • menu

    Company profile for Trogenix

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Trogenix is innovating cancer therapies by combining genomics, synthetic biology, gene therapy, and immunotherapy to target solid tumors with high precision. Their proprietary Synthetic Super-Enhancers (SSEs) technology, delivered through Adeno-Associated Virus (AAV) vectors, enables potential "one-and-done" personalized, in situ vaccinations for aggressive cancers. This approach promises to revolutionize cancer treatment by o...
    Trogenix is innovating cancer therapies by combining genomics, synthetic biology, gene therapy, and immunotherapy to target solid tumors with high precision. Their proprietary Synthetic Super-Enhancers (SSEs) technology, delivered through Adeno-Associated Virus (AAV) vectors, enables potential "one-and-done" personalized, in situ vaccinations for aggressive cancers. This approach promises to revolutionize cancer treatment by offering curative, personalized solutions for tough-to-treat tumors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Trogenixunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    4‑5 Little France Drive IRR North Building BioQuarter Edinburgh
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://trogenix.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Trogenix Raises 70M Series A To Advance Curative Cancer Therapies
    Trogenix Raises 70M Series A To Advance Curative Cancer Therapies

    06 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/06/3161407/0/en/Trogenix-announces-70-million-95-million-Series-A-financing-to-drive-clinical-development-of-potentially-curative-therapies-for-aggressive-cancers.html

    GLOBENEWSWIRE
    06 Oct 2025
    Share Share
    Trogenix Appoints Atif Abbas as CMO, Carolyn as VP
    Trogenix Appoints Atif Abbas as CMO, Carolyn as VP

    18 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/18/3117720/0/en/Trogenix-Bolsters-Clinical-Research-Team-with-Appointment-of-Atif-Abbas-as-Chief-Medical-Officer-and-Carolyn-Edwards-as-Vice-President-Research-Development.html

    GLOBENEWSWIRE
    18 Jul 2025
    Share Share
    Trogenix strengthens Board with Prof Nada & Prof Burkhard
    Trogenix strengthens Board with Prof Nada & Prof Burkhard

    07 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/07/3075749/0/en/Trogenix-Further-Strengthens-its-Scientific-Advisory-Board-with-the-Appointment-of-World-Leading-Experts-Prof-Nada-Jabado-and-Prof-Burkhard-Becher.html

    GLOBENEWSWIRE
    07 May 2025
    Share Share
    Viralgen partners Trogenix to AAV gene therapy for glioblastoma
    Viralgen partners Trogenix to AAV gene therapy for glioblastoma

    06 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/viralgen-collaborates-with-trogenix-to-advance-aav-gene-therapy-for-glioblastoma-302445018.html

    PR NEWSWIRE
    06 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search